A study on 18F-FDG PET/CT imaging assessment of the anti-aging efficacy of BMMSCs in the macaque brain Authors: Pinghui Li, Yaxi Jiang, Xinghua Pan, Xiangqing Zhu, Baoci Shan, Tingting Pan, Shici Yang, Qinghua Li, Ting Li, Jie Li, Lilin Chen, Rui He, Fei Xie, Gaohong Zhu Published: 2026 ABSTRACT AbstractObjectiveAging is a pressing global challenge requiring urgent solutions, and the anti-aging potential of mesenchymal stem cells (MSCs) has drawn global attention. This study treated aged macaques with bone marrow mesenchymal stem cells (BMMSCs) and aimed to establish a non-invasive, reliable, specific, and reproducible imaging method for evaluating BMMSCs’ therapeutic effects by combining 18F-FDG PET/CT imaging with texture analysis and Statistical Parametric Mapping 8.0 (SPM8.0).MethodsSixteen healthy female macaques were split into three age groups: juvenile, young, and elderly. Baseline 18F-FDG PET/CT imaging was conducted, and only the elderly group received BMMSC transplantation. Brain PET/CT scans were repeated 3 and 6 months post-treatment. PET data were processed using PET Vcar (for metabolic analysis), LIFEx (for texture feature extraction), and SPM8.0 (for pixel-wise statistical mapping).ResultsThe elderly group had a higher metabolic volume (MTV) than the juvenile group, which declined after BMMSC treatment. However, no significant differences in SUVmax, SUVmean, or TLG were found in the elderly group post-treatment. Texture analysis identified SHAPE_Surface and GLZLM_LZLGE as strong classification markers, with ROC curve AUC values of 0.833 and 0.75, respectively. SPM 8.0 analysis showed BMMSCs improved glucose metabolism in the entorhinal and auditory cortices of aged macaques.ConclusionsBMMSC treatment improved glucose metabolism in specific functional brain regions (auditory processing, motor ability, cognitive memory, vision, taste, and reproductive systems) of aged macaques. 18F-FDG PET/CT plus texture analysis and SPM8.0 is a credible, accurate quantitative methods for assessing BMMSC efficacy. We established a multimodal 18F-FDG PET/CT framework (metabolic analysis, texture extraction, and SPM8.0) to assess BMMSCs’ anti-aging effects in macaque brains. BMMSCs restored glucose metabolism in key functional brain regions (entorhinal, auditory, and motor cortices) of aged macaques; SHAPE_Surface and GLZLM_LZLGE were identified as reliable aging-related texture biomarkers. This work validates BMMSCs’ translational potential for brain anti-aging, provides a standardized non-invasive imaging approach for preclinical stem cell therapy evaluation, and fills a gap in non-human primate functional brain aging research, accelerating the development of human healthy brain aging interventions. Introduction The brain is the highest nerve center of the living organism and regulates a variety of life activities, including learning, movement, and cognition, through a complex network of neurosynapses. Aging of the brain is often accompanied by degenerative changes such as cognitive decompensation and neuroinflammation. Non-human primates such as macaques share similarities with humans in terms of physiological functions, genetic characteristics, and developmental trajectories, which exhibit similar age-related patterns of change in number and volume.1,2 Therefore, the macaque rhesus was widely used to characterize brain aging models and help to understand human changes in trajectories of brain development, maturation, and aging. It is crucial for assessing potentially relevant human diseases and ways of interventions. Mesenchymal stem cells (MSCs) have garnered global attention due to their multipotency, immunomodulatory properties, and demonstrated therapeutic potential in tissue regeneration, with extensive in vitro and in vivo studies revealing their anti-inflammatory, anti-aging, reconstructive, and wound-healing capacities.3 Studies have shown that bone marrow mesenchymal stem cells (BMMSCs) reduce the microglia-mediated neuroinflammation after cortical injury in aged macaques and improve motor function in aged female macaques.4,5 In addition, rodent experiments have shown that BMMSC treatment improves spatial memory by increasing the number of neuroblasts in their hippocampal dentate gyrus and restoring presynaptic protein levels.6 However, these methods exhibit high invasiveness and poor reproducibility, and face significant challenges in clinical translation. Recent advances in neuroimaging have driven a paradigm shift in anti-aging assessment, with emerging methodologies prioritizing noninvasive approaches, quantitative biomarkers, and enhanced reproducibility.7–10 Traditional computed tomography (CT) and magnetic resonance imaging (MRI) can detect age-related changes in brain morphological structures. MRI can quantify the morphological integrity of gray and white matter in the brain and diagnose abnormal brain structures early. Studies have shown that cortical thickness, especially somatosensory and motor cortex thickness, exhibits a negative correlation with age in macaques.11 In addition, gray matter volume decreases progressively with age, and white matter fractional diffusion anisotropy generally decreases, as does radial diffusion rate.12 In addition to the structural and morphological abnormalities, brain glucose metabolism also changes with aging. Nuclear medicine technology such as positron emission tomography (PET) can further quantify the functional and metabolic characteristics of the brain and other organs at the molecular level. Glucose is the main energy substance for brain energy metabolism.13 18F-flurodeoxyglucose (18F-FDG), a glucose analogue chemically synthesized by 18F radiolabeling that maintains identical biological behavior to native glucose,14 serves as the most widely utilized PET imaging tracer for metabolic assessment. It can enter the cell through the glucose transporter on the cell membrane and remain in the cell. 18F-FDG uptakes can reflect the utilization of glucose by neurons in the brain and finally form a tomographic fusion image with metabolic information of physiological functions. In 2002, Akihiro observed that the local cerebral blood flow and local cerebral glucose metabolism rates were significantly lower in aged macaques than in young macaques using 18F-FDG PET/CT.15 The rapid advancement of image processing technology has significantly improved the accuracy of quantitative brain glucose metabolism analysis. Adopting a precision medicine framework, radiomics characterizes lesion heterogeneity through computational pixel-wise analysis and high-dimensional data mining.16,17 When integrated with deep learning techniques, this approach shows promising potential for assessing aging phenotypes and therapeutic efficacy. PET/CT involves multiple metabolic parameters for quantitative analysis. Quantitative evaluation of 18F-FDG uptakes by PET Vcar can be used to reflect disease progression and predict outcomes. Standardized uptake value (SUV), standard uptake value of lean body weight (SUL), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) are commonly used. Total lesion glycolysis (TLG) is common PET metabolic parameter for semi-quantitative assessment of lesion characteristics.18 Currently, texture analysis has been widely applied to tumor lesions across multiple organ systems, effectively revealing intratumoral heterogeneity and contributing to the differentiation of benign and malignant diseases, prognosis assessment, as well as the prediction of recurrence/metastasis risks and exploration of molecular markers.19–22 Recently, texture analysis has also been applied to neurodegenerative diseases. Studies demonstrate that the combination of 18F-FDG PET imaging and texture analysis improves diagnostic accuracy in differentiating Alzheimer’s disease, mild cognitive impairment, and Parkinson’s disease from normal controls.23,24 LIFEx is a non-commercial open-source software focused on automatically extracting a large number of texture features from various imaging images such as CT, MRI, single photon emission computed tomography (SPECT), and PET,25 which can reveal microscopic information about the brain in PET macroscopic images. With the rapid advancement of computational statistical techniques, Statistical Parametric Mapping (SPM8.0), originally developed by British neuroscientist Karl Friston, emerged as a versatile software package for neuroimaging analysis. Primarily designed for functional neuroimaging modalities (eg, SPECT, PET, and MRI), it has become a standard tool for investigating brain lesions and functional neuroanatomy. With advancements in PET technology for functional brain imaging, the application and refinement of SPM8.0 were significantly advanced by researchers such as Shan et al., ultimately establishing it as the gold standard for PET data processing.26–28 It analyzes all pixels in a 3D image and performs statistical analysis one by one, with individual pixels as the smallest unit. The parameters of the analysis results are integrated into a digital atlas of the brain to distinguish functional brain regions. Initially, Zeki29 used SPM8.0 combined with PET cerebral blood flow measurements and found that in humans, as in macaques, different regions of the visual cortex are specialized to process different visual stimuli. Xu30 found that the SPM method combined with PET imaging is important for the diagnosis of early dementia and that elderly people have predominantly reduced glucose metabolism in the gray matter of the brain bilaterally, including the cingulate gyrus, parahippocampus gyrus, and bilateral middle frontal gyrus. They showed increased metabolism in the thalamus, anterior cerebellum, middle occipital gyrus, and parietal lobe bilaterally. However, differences in glucose metabolism in functional brain regions in the aging brain of macaques have not been reported. In this study, the PET metabolic parameters from PET Vcar, LIFEx, and SPM8.0 were used to quantitatively evaluate the changes in brain PET/CT glucose metabolism during aging and improvements of functional brain regions after BMMSCs transplantation treatment in macaques, aiming to establish a reliable and non-invasive method to assess the efficacy of BMMSCs transplantation and provide a theoretical basis for clinical translation of stem cells. Materials and methods Experimental animals Experimental macaques were provided by the Kunming Institute of Zoology, Chinese Sciences Academy. The Latin name “Macaca” of the macaque species. Sixteen macaques were screened by a professional veterinarian for physical examination and were in good health without any previous brain disease. Inclusion criteria: female macaques aged 2-26 years, healthy status confirmed by physical examination (normal blood chemistry, no history of brain disease or inflammation), and stable body weight (±10% over 1 month prior to enrollment). Exclusion criteria: abnormal blood glucose levels (>8 mmol/L) before imaging, adverse reactions to anesthesia, or incomplete imaging/data collection. To minimize confounders, all rhesus macaques were housed in a conventional environment under standard husbandry conditions, with a controlled temperature of 23 ± 1 °C and relative humidity of 60 ± 5%. Only those showing no abnormalities after a minimum of 2 weeks of acclimation and observation were enrolled in the study. They were divided into the juvenile group (5 animals, average age 2 years, body mass 4-6 kg), the young group (5 animals, average age 12 years, body mass 6-12 kg) and the elderly group (6 animals, average age 24 years, body mass 5-10 kg). Baseline of 18F-FDG PET/CT brain imaging was performed. Then, six macaques in the elderly group were treated with BMMSCs for anti-aging. The 3M-elderly and 6M-elderly groups were followed as two elderly treatment groups (3 months after treatment in the elderly group and 6 months after treatment in the elderly group). Experimental animals were randomly assigned to the control and treatment groups using a random number table, with the randomization sequence generated by an independent researcher. 18F-FDG PET/CT brain images were scanned under the same conditions in the elderly, 3M-elderly, and 6M-elderly groups. Since macaques are precious and this study did not involve anatomical specimens, the animal models were not euthanized. Blinding was implemented at three stages: (1) Treatment administration: The researcher administering BMMSCs or saline was unaware of the group assignment (juvenile/young/elderly); (2) Data collection: Behavioral observers and technicians performing PET/CT imaging were blinded to the treatment status; (3) Data analysis: Image analysts (processing PET Vcar, LIFEx, and SPM8.0 data) and statisticians were blinded to the group assignment until the final statistical analysis was completed. Blinding was maintained using coded identifiers for all samples and images. The main equipment and reagents of the experiment Equipments DiscoveryTM PET/CT Elite, MINItrace Kirin Cyclotron, Tracelab FDG Synthesizer, GE Healthcare AW4.6 Post-Processing Workstation, PET Vcar (PET volume computed assisted reading) software, LIFEx 7.1.0 software (https://www.lifexsoft.org/), and SPM 8.0 software (https://www.fil.ion.ucl.ac.uk/spm/). Reagents Bone marrow mesenchymal stem cell medium of juvenile macaque, fetal bovine serum, 0.25% trypsin, DMEM/F12 medium, FITC anti-human CD29, FITC anti-human CD34, FITC anti-human CD90, FITC anti-human CD105, and sex hormone kit. All reagents were sourced from Thermo Fisher Scientific. Behavioral experiments and sex hormone testing Behavioral experiments All macaques were placed in a rectangular space of 5 × 7 m2 for behavioral testing. The space required no noise and sufficient light testing items, including general status, number of white facial hairs, movement, and stopping behavior, while photographic records were taken by professional staff. First, a physical examination was performed to record the macaque ID, sex, age, weight, and length. The general status includes age, hair color, facial features, posture, eye appearance, spirit, diet, and sleep. The number of white facial hairs was recorded as the ratio of the number of white hairs to the number of normal hairs in the same area. The movement and pause behavior included the frequency of movements, movement distance, movement duration, limb activity, head-turning times, head lowering times, and the times of pause and pause time. The above movements were recorded in the morning, middle, and evening for 10 min. All observations were performed by two trained observers blinded to the group assignment. Exercise duration was defined as the total time (seconds) spent moving (walking, climbing, or grooming) per 10-min session; exercise distance was measured using video tracking software; pause time was the total time (seconds) spent in a stationary posture (sitting or lying down). 'Improvement’ was quantitatively defined as a statistically significant increase in exercise duration/distance or decrease in pause time compared to pre-treatment baseline, using paired t-tests. Sex hormone assays All 16 female macaques were fasted and dehydrated for at least 6 hours before the assay. General anesthesia was administered via the elbow vein using 3% pentobarbital 1 ml/kg (by body mass). Then, 5 mL of hindlimb venous blood was collected into a non-anticoagulated vacuum blood collection tube for the sex hormone assays. These included prolactin (PRL), follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Müllerian hormone (AMH), estradiol (ESTRDL), testosterone (Testo), and progesterone (Prog). Enzyme chemiluminescence and electrochemiluminescence assays were used for detection, performed strictly according to the kit manufacturer’s instructions. Sex hormone testing was repeated at 3 months and 6 months post-treatment in the elderly group. BMMSCs preparation, culture, identification, and transplantation BMMSCs of juvenile macaques Juvenile female macaques were anesthetized under sterile conditions by intramuscular injection of 3% sodium pentobarbital (1 mL/kg). Approximately 5 mL of bone marrow aspirate was obtained from the iliac crest and immediately transferred into a 50-mL centrifuge tube containing an equal volume of heparin. Subsequently, five volumes of red blood cell lysis buffer were added, followed by centrifugation at 1900 rpm for 10 min. The supernatant was discarded, and the cell pellet was washed once or twice with normal saline. The cells were then gently resuspended in 1 mL of complete bone marrow mesenchymal stem cell culture medium and cultured in a humidified incubator at 37 °C with 5% CO2 (Figure 1). The expression of surface markers CD29, CD34, CD90, and CD105 on BMMSCs was analyzed by flow cytometry. A. The schematic diagram of bone marrow mesenchymal stem cell isolation. B. The technical route of this study. BMMSCs transplantation When the fourth generation BMMSCs reached confluent to about 90% in the culture flask, discard the supernatant. Then, 15 mL of physiological saline was added and washed three times, followed by discarding the saline. Next, add 3 mL of trypsin containing 0.25% EDTA to digest for 3 min. Finally, 6 mL of DMEM/F12 basal medium was added to terminate the digestion. After centrifugation at 2000 rpm for 3 min, the supernatant was aspirated. Then, add 3 mL of physiological saline, which was resuspended, mix well and adjust the cell concentration to 2 × 109/L. Finally, the cells were transferred into a 50 mL syringe. The macaque was anesthetized with 3% sodium pentobarbital (1 kg/mL) through the femoral vein. They were fixed on the operating table, and BMMSCs was infused into the elderly treatment group through the femoral vein at a dose of 1 × 107/kg. The BMMSCs treatment consisted of a single course: three intravenous infusions via the femoral vein, administered every other day (total of 3 doses). Macaques in the juvenile and the young group were infused with an equal volumes of normal saline simultaneously. 18F-FDG PET/CT imaging The imaging agent 18F-FDG was synthesized by GE’s MINItrace Kirin cyclotron and Tracerlab FDG synthesizer, with radiochemical purity >99%. Before imaging, fasting blood glucose <8 mmol/L was confirmed in macaques. Subsequently, the macaques brain images were acquired using PET/CT scanner (DiscoveryTM PET/CT Elite, GE Healthcare, USA). The macaques were injected intravenously with 18F-FDG at 0.3 mCi/kg (by body mass) and placed in a quiet and dark room for 40 min after the injection. Vital signs of macaques were monitored during the experiment. First, a conventional spiral scan of the head CT was performed from the skull vertex to the middle of the neck, followed by PET imaging with the macaque ID, weight, age, and injection dose recorded. The acquisition parameters were set as follows: tube voltage: 120 kV, tube current: 260 mA, pitch: 0.561, rotation speed: 0.5 s/rotation, layer thickness: 3.75 mm, interval: 3.75 mm, matrix: 512 × 512, FOV: 50 cm × 50 cm, scan time per bed: 2.5 min, and attenuation correction applied. After image acquisition was completed, the macaques were returned to the monkey cage to await natural recovery. Image data processing and analysis PET metabolic parameter data processing All images were transferred to the PET Vcar software at the GE Healthcare AW4.6 post-processing workstation for processing, which automatically outlines the volume of interest (VOI) of the cerebral cortex by the adaptive threshold method to determine the boundaries of glucose metabolism and automatically calculates the brain’s glucose metabolism index: maximum standardized uptake value (SUVmax), average standardized uptake value (SUVmean), MTV, TLG, and standard lean body mass uptake peak (SULpeak). VOI was saved as an RTStruct format file. LIFEx data processing The PET/CT images in DICOM format and the corresponding marker files in RTStruct format were imported into LIFEx 7.1.0 software, and the shape features, histogram features, and conventional/discretized features in the VOIs were automatically extracted by the default setting. The first-order features, gray level co-occurrence matrix (GLCM), gray level run-length matrix (GLRLM), neighboring gray level difference matrix (NGLDM), gray level zone length matrix (GLZLM), and other second-order texture features were automatically extracted from VOIs. SPM8.0 image data processing Brain PET/CT images in DICOM format were converted to SPM8.0 compatible format using MRIcron software and imported into SPM8.0, and the standard brain atlas of macaque was pre-implemented based on the macaque brain template (HJT) jointly developed by the laboratory of the Institute of High Energy Physics, Chinese Academy of Sciences, and Jinan University31 (Figure 2). The PET images were reconstructed into a 1 mm × 1 mm × 1 mm voxel size image by applying affine transformation and local nonlinear correction to unify it into the standard space, and the internal anatomical regions were aligned with the brain template and then smoothed in the standard space using Gaussian function It was aligned with the digital atlas of macaque brain to delineate the cortical functional areas(Shan B, 2021) and analyzed voxel-wise at a threshold of 50 voxels. The different pixels were matched with the functional brain area, and the positive and negative differences in brain areas between each group were obtained. HJT brain template, different colors represents different functional brain regions.28 Statistical processing IBM SPSS 26.0 software was used to process the data, and quantitative data were represented by mean ± standard deviation (x̅ ± SD), and all data were tested by K-S normality and analysis of variance. All variables were normally distributed. The five PET metabolic parameters (SUVmax, SUVmean, SULpeak, MTV, and TLG) and sex hormone levels were compared with one-way ANOVA. Whole brain texture feature parameter analysis was performed using IPMs (GE Healthcare, Shanghai) software. Univariate logistic analysis was performed at P < .05. The ROC curves of the differential texture parameters were established, and the area under the curve (AUC), sensitivity, and specificity were calculated. The PET image of the brain after spatial normalization and smoothing was analyzed pixel-by-pixel using SPM8.0 software, and each pixel data was modeled using a generalized linear model at a certain voxel threshold (cluster size = 50). The test level (P < .05) of the model parameters was tested by two sets of independent samples; the pixels with significant statistical differences were extracted to obtain a statistical parameter graph, and the t-value was converted to the Z-value using the probability transformation Z score. Pixel coordinates in the statistical parameter maps were anatomically localized using the standard brain atlas of macaques to obtain brain regions with significant differences in glucose metabolism, with warm tones representing positive differences and cool tones representing negative differences. Results Aging macaque model evaluation Physical examination showed that all macaques were well-grown and developing, and all indicators were within the normal range. The morphology of juvenile, young, and elderly macaques was shown in Figure 3A. Posture: Juveniles and young macaques were mentally active, primarily exhibiting climbing postures, whereas elderly macaques showed poor mobility, inflexibility, and predominantly sitting postures. The difference was statistically significant (Figure 3B, P < .05). The activity of the macaque increased after treatment, and the difference was not statistically significant (Figure 3C, P > .05). The number of white facial hairs: Juvenile macaques had a clean face with shiny-feeling hairs and <10% white hairs; old macaques had a red face, loose skin, dull and non-shiny hairs, and more than 30% of white facial hairs, young macaques were between the two. The difference was statistically significant after BMMSC treatment, in which macaques had a decrease in facial white hair count (Figure 3D, P < .05). Times of exercises: Juvenile macaques exercise for a longer distance and a longer time than the elderly macaque at the same time. Young macaques showed the fewest movements and shortest pause times. Significant intergroup differences were observed (Figure 3E, P < .05). Intergroup differences in movement duration and distance were nonsignificant (P > .05). Elderly macaques showed significantly lower AMH levels versus juveniles (Figure 3F, P < .05). Young macaques had higher ESTRDL levels than juveniles, with significant intergroup differences. After BMMSCs treatment, the ESTRDL improved but did not have a statistical difference (Figure 3G, P > .05). In summary, the natural aging macaque model was successfully constructed. The anti-aging efficacy of BMMSCs was evaluated by imaging based on this model. Evaluation of natural aging macaque model. A1. Juvenile macaque model. A2. Young macaque model. A3. Elderly macaque model. B. Age distribution between groups, except for the elderly group and the treatment group, there were statistical differences between the remaining groups (P < .05). C. There were statistical differences among the young group, elderly group, and the treatment group in the postural behavior test (P < .05). D. Facial white hair count detection. E. Exercise times test. F. ESTRDL test: There was a significant difference between the juvenile and the young (P < .05). G. AMH test, there was a significant difference between the juvenile and the elderly (P < .05). Bone marrow mesenchymal stem cells observed In our team’s previous research work, the BMMSCs were cultivated by the whole bone marrow tissue block apposition method and observed under an inverted microscope with obvious short spindle-shaped cells crawling out after 24 h and long spindle-shaped at 7-8 d. By the flow analysis of P4 generation BMMSCs, the results showed positive expression of BMMSCs surface antigens CD29, CD34, CD90, and CD105 at 97.3%, 1.5%, 98.4%, and 99.8%. In summary, the morphological observation and the detection of specific antigenic markers on the cell surface indicated that the cultivated cells were BMMSCs. PET/CT image quality evaluation The CT images showed clear brain tissue density and morphology, no artifacts, and no deflection. PET and CT images were well registered (Figure 4A-C). PET/CT brain imaging in macaques. A. A1∼A5 represent brain PET images (sagittal view) of juvenile/young/elderly/3 m-elderly/6 m-elderly group. B. B1∼B5 represent brain CT images (sagittal) of juvenile/young/elderly/3 m-elderly/6 m-elderly group. C. C1∼C5 represent juvenile/young/elderly/3 m-elderly/6 m-elderly group brain PET/CT fusion image (sagittal). D. PET Vcar outlines metabolic regions of the macaque brain. E∼I. PET Vcar measured the changing trend of the brain metabolic parameters of macaques. The parameters were MTV, SULpeak, SUVmax, SUVmean, and TLG in order. Trends in the metabolic parameters of PET vcar First, delineate the metabolic regions of the macaque brain (Figure 4D). MTV increased with age. MTV in the elderly group was significantly higher than that in the juvenile group (Figure 4E, P < .05). It gradually decreased after treatment of BMMSCs, with no statistical differences between the other groups. SULpeak, SUVmax, SUVmean, and TLG were the highest in the juvenile group and lowest in the young group. The elderly group was mildly elevated compared with the young group. There were no significant differences between the elderly and BMMSCs treated groups (Figure 4F-I, P > .05). LIFEx brain PET image texture analysis PET imaging successfully outlined the macaque brain VOIs (Figure S1A). LIFEx software automatically extracted 68 texture features from each VOI, including first-order texture features, 5 shape features, and 6 Histogram features, and 22 conventional/discretized features, second-order texture features such as 7 Gray Level Co-occurrence Matrix (GLCM). Higher-order texture features included 11 gray levels run-length matrix (GLRLM), neighboring gray level difference matrix (NGLDM), and 11 high-order texture features, including the gray level zone length matrix (GLZLM) (Figure S1B). After univariate logistic analysis, SHAPE_Surface (mm2) and GLZLM_LZLGE can be used as independent markers. The cutoff values of the two were 15360 and 5203. ROC analysis of the first marker showed an AUC of 0.833, sensitivity of 0.6, and specificity of 1.0. The second marker had an AUC of 0.75, sensitivity of 0.5, and specificity of 0.9 (Figure S1C, D and Table S1). SPM8.0 analyzes The brain PET images were analyzed pixel by pixel in SPM8.0 software, and based on the HJT macaque brain atlas, 44 bilateral brain functional areas and the whole brain (a total of 89 functional brain areas) were accurately delineated. The positive and negative differences in functional areas were obtained between the groups. Glucose metabolism in macaque brain functional areas showed differential trends across age groups and post-BMMSC treatment. In elderly macaques, glucose metabolism was significantly lower than in young macaques in the bilateral auditory cortex medial area, lateral geniculate nucleus, left entorhinal cortex, and bilateral lateral geniculate nucleus (P = .001, P = .023, P = .027, P = .027, .039, and P = .024). Changes in brain glucose metabolism were predominantly right-sided in the elderly group after BMMSC treatment compared to before treatment. In the 3M-elderly group, glucose metabolism in the core region of the right entorhinal cortex, dentate gyrus, and core areas of the auditory cortex was significantly higher than in the elderly (P < .001, P = .003, P = .003). In 6M-elderly macaques, glucose metabolism increased significantly versus pretreatment in the right ectorhinal cortex and ventral premotor cortex (P = .001, P = .002). BMMSCs-treated elderly macaques showed both increased and decreased glucose metabolism relative to young macaques, predominantly in right hemispheric regions. In the 3M-elderly group, glucose metabolism was significantly increased in the right entorhinal cortex, insular gustatory cortex, lateral geniculate nucleus, primary motor cortex, left auditory cortex core area, and bilateral motor area (P = .007, P = .01, P = .012, P = .014, P < .001, P = .016). The glucose metabolism in the right dentate gyrus, the entorhinal cortex, the bilateral thalamus mammillary nucleus, and the lateral geniculate nucleus was significantly reduced (P = .004, P = .005, P = .01, P = .021, P = .008, and P = .01). Among them, the inner olfactory cortex and the right lateral geniculate glucose metabolism showed bidirectional changes. In the comparison of glucose metabolism across brain regions, the 6M-elderly group showed significant differences versus the 3M-elderly in right auditory cortex core and dorsolateral premotor cortex increases; versus left hippocampus, external olfactory cortex, primary motor cortex, and bilateral lateral geniculate nucleus decreases (P = .036, P = .027, P = .03, P = .033, P = .027, P = .004, P = .01). Group-wise differences in cerebral glucose metabolism are detailed in Figure 5 and Table S2. SPM analysis of metabolic differences in brain regions between macaque groups. Regions showing relatively increased metabolism are indicated by positively scaled regions, and regions showing relatively decreased metabolism are indicated by negatively scaled regions. A. Relative to the elderly group, the 3M‑elderly group shows increased metabolism in the highlighted brain regions (P = .01, cluster size = 50). B. Relative to the young group, the 3M‑elderly group shows increased metabolism in positively scaled brain regions and decreased metabolism in negatively scaled brain regions (P = .05, cluster size = 50).C. Relative to the elderly group, the 6M‑elderly group shows increased metabolism in positively scaled brain regions (P = .005, cluster size = 50). D. Relative to the 3M‑elderly group, the 6M‑elderly group shows increased metabolism in positively scaled brain regions (P = .05, cluster size = 50). E. Relative to the young group, the 6M‑elderly group shows increased metabolism in positively scaled brain regions (P = .05, cluster size = 50). F. Relative to the young group, the elderly group shows decreased metabolism in negatively scaled brain regions (P = .05, cluster size = 50). Values on the color scale represent Z‑scores derived from probability transformation of pixel‑wise t‑values from statistical comparisons. Discussion This study is based on the core logic that “brain functional status is closely associated with glucose metabolism level: 18F-FDG, as a glucose analog, can enter and accumulate in cells via glucose transporters on neuronal membranes after intravenous injection, and PET/CT scanning generates fused images reflecting the spatial distribution and intensity of cerebral glucose metabolism; meanwhile, BMMSCs can improve neuronal activity in functional brain regions of aged macaques (eg, the entorhinal cortex related to cognitive memory, the auditory cortex related to auditory processing, etc.), thereby altering local glucose metabolism levels. A variety of methods of processing image data were used to analyze the 18F-FDG PET/CT images of macaque brains. To a certain extent, it revealed the brain aging pattern of macaque and the reversal effect of BMMSCs on brain functional areas after anti-aging treatments. The PET metabolic parameters and texture analysis techniques reveal the overall trend of whole-brain glucose metabolism, offering a simple, rapid, and easy-to-implement evaluation method. Compared to traditional PET metabolic parameters and texture analysis techniques, SPM8.0 enables more precise quantification of glucose metabolism differences in various functional brain regions before and after BMMSCs treatment in macaques, albeit with increased procedural complexity. We first assessed whole-brain glucose metabolism using five PET metabolic parameters commonly used in clinical, including SUVmax, SUVmean, TLG, MTV, and SULpeak. SUV accurately estimates the concentration of 18F-FDG uptake in the lesion. It is standardized for body weight and more accurately reflects the glucose uptake capacity of the lesion by measuring lean body weight. But it is highly impacted by blood glucose and uptake time. MTV is an important parameter that responds to the size of the lesion activity, which excludes local areas of non-metabolic activity such as necrotic tissue of the lesion, and has a high correlation to the pathological response. TLG can be obtained from the mean standardized uptake value (SUVmean) × MTV, which is the sum of the SUV within the lesion. And it has an important predictive value with MTV. In this study, our results indicated that brain glucose metabolism first decreased and then slightly increased with BMMSC treatment. After BMMSC treatment, brain metabolism decreased slightly. The slightly higher cerebral glucose metabolism in the elderly group than in the young group may be related to the smaller sample size, and the difference was not statistically significant. In 1995, Eberling32 used 18F-FDG PET to study the change in the metabolic rate of the brain region of rhesus macaques. The local glucose metabolism rate of elderly rhesus macaques was significantly lower than that of young rhesus macaques. This is consistent with our results. Noda15 further compared the local cerebral blood flow and local brain glucose metabolic rate of young and elderly rhesus macaques. They found that the blood flow of the cerebellum, hippocampus, parahippocampus gyrus, striatum, occipital cortex, temporal cortex, and frontal cortex of elderly rhesus macaques was significantly lower than that of young rhesus macaques. There was a significant correlation between local cerebral blood flow and local cerebral glucose metabolic rate. Whole-brain PET image texture analysis, which is an image processing technique based on imaging data to extract information from images. PET image texture analysis can obtain the spatial distribution patterns of molecular metabolism.33 The results of this study showed that both SHAPE_Surface (mm2) and GLZLM_LZLGE have the best classification ability between young/juvenile and elderly groups. The shape feature describes the size of the surface area of the 3D region of interest,34 suggesting that the cortical surface area after BMMSCs treatment has a tendency to reverse toward the juvenile and young macaque. GLZLM, the Grey-Level Zone Length Matrix, refers to the gray-level zone length matrix providing information about the size of homogeneous regions at each gray level in 3D or 2D.35 GLZLM_LZLGE, on the other hand, represents the distribution of long homogeneous regions at low gray levels, suggesting that as macaques age, brain PET images converge more and more to a large homogeneous low grayscale pattern with reduced overall brain metabolism, which can be significantly altered by BMMSC treatment. As early as 1999, Andersen36 revealed female macaque brain volume changes with aging. Before the age of 15, the decline of brain volume with age was almost entirely caused by the reduction of gray matter area. This decrease slowed after age 15. The results of our present study are consistent with this. Using the above two imaging data processing methods, we only confirmed that glucose metabolism is reduced in the aging macaque brain and found that two texture markers can independently assess the efficacy of BMMSCs. In order to observe which functional brain areas benefit from these changes, we further investigated them using PET standard brain mapping in macaques in combination with the SPM8.0 method. The Cross37 team used the macaque brain map to characterize the glucose metabolism activity of the macaque brain in the stereotactic coordinate system on a pixel-by-pixel basis. They found that the central groove and occipital cortical glucose metabolism varied greatly in macaques of different ages, and the glucose metabolism in the occipital caudal nucleus and temporal lobe cortex of the elderly macaques was the most significant. The medial region of the auditory cortex is considered an early auditory, auditory processing area, and Pawel Kusmierek38 recorded with microelectrodes different neuronal responses to the macaque auditory cortex under different sound tones, and the results showed that the medial region was highly selective about all sound stimuli compared to the core region, especially sudden bursts of noise. The entorhinal cortex, located deep in the medial temporal lobe, plays a key role in the hippocampal formation, mastering the spatial memory function of macaques.39 During macaque aging, adult macaques first develop phosphorylation and amyloid deposition in the olfactory cortex of the same tau protein as humans and progress to fibrous tangles in old age, which may lead to the onset of late-onset Alzheimer’s disease.40 The lateral geniculate nucleus relays visual information from the thalamus to the cerebral cortex. During aging, visual abilities are degraded due to neuronal changes in the central visual pathway.41,42 The results of the SPM8.0 pixel-by-pixel analysis of this study showed that the glucose metabolism in the medial region of both sides of the auditory senses of the elderly macaques decreased significantly, which may be related to the loss of hearing ability and the decline of the sound threshold. The decreased glucose metabolism of the entorhinal cortex may be related to cognitive impairment, and the decrease in glucose metabolism of the lateral geniculate nucleus may be related to senile vision degeneration. The entorhinal cortex is a subregion of the olfactory cortex that is closely with perirhinal cortex.43 There is no report on the functional study of the ectorhinal cortex of the macaque. The hippocampus is a key brain region for memory, and the dentate gyrus plays an irreplaceable role in this process. Scott44 has shown that the dentate gyrus is the hippocampus region most sensitive to age. Yuko45 further suggests that decreased GRUA2 density in the dentate gyrus of elderly rhesus macaques will lead to memory deficits. The ventral anterior motor cortex controls motor proficiency, which is associated with the macaque’s hand grasping ability.46 The results of our study showed that the glucose metabolism in the entorhinal cortex, dentate gyrus, auditory cortex core area, and ventral anterior motor cortex was significantly higher than before treatment at 3M-elderly and 6M-elderly. After BMMSCs treatment, the observed increase in glucose metabolism in the ventral premotor cortex (a key region for motor planning and execution) is consistent with the behavioral finding of increased movement frequency in the elderly group post-treatment (Figure 3E). While we did not specifically test fine motor skills, the improved motor activity and posture (Figure 3B and C) suggest functional benefits in motor control, which warrants further investigation with targeted motor tests in future studies. BMMSCs therapy may be expected to be applied to prevent the occurrence of Alzheimer’s disease. The insular gustatory cortex serves as primates’ primary taste center. Like the orbitofrontal taste cortex, the insula gustatory cortex represents a stage of information processing in the primate taste system, which can not only represent the sense of taste but also represent a variety of oral stimuli, such as the texture, viscosity, fat taste, granularity, temperature, and spiciness of food.47–49 In 2004, Liang50 used 18F-FDG PET to combine SPM8.0. The method locates the sweet taste center of the human brain, and the results showed that the sweet sense has the largest activation range on the insula. Silverman51 immunochemical studies with thick and unencapsulated tissue slices found that luteinizing hormone-releasing hormone (LHRH) neuronal axons innervate the medial mamillary nucleus, regulating the secretion of gonadotropin in primates. At 3 and 6 months after BMMSCs treatment, glucose metabolism in the core area of the auditory cortex, entorhinal cortex, gustatory cortex, lateral geniculate nucleus, primary motor cortex, motor area, medial area of the auditory cortex, and mamillary body was significantly higher than that of the young group. Among them, glucose metabolism in the brain areas of auditory, taste, vision, and motor were significantly increased at 3 and 6 months after treatment, suggesting that BMMSC treatment continued to reverse the somatosensory function of the elderly macaques and change the perception of young macaques. In addition, mamillary nucleus glucose metabolism in 3M-elderly was significantly lower than that of young macaques and significantly higher than that of young macaques at 6 months after treatment, suggesting that reproductive function improved best at 6 months after treatment, which was consistent with our previous research conclusions.52 The 6 months after BMMSC treatment showed further functional improvement in the bilateral lateral geniculate nucleus, motor cortex, entorhinal cortex, and auditory core area of macaques compared with 3 months after treatment. Given the intravenous administration route, we think that BMMSCs exert their anti-aging effects on the brain primarily via a paracrine mechanism. BMMSCs secrete a variety of trophic factors (eg, BDNF, GDNF, IL-10) and extracellular vesicles that can cross the BBB4,5 to reduce neuroinflammation, promote synaptic plasticity, and enhance glucose metabolism in functional brain regions. This is consistent with rodent studies showing that BMMSCs-derived factors improve spatial memory and hippocampal neurogenesis without direct neuronal integration.6 Currently, our team is advancing the radiotracer technology for BMMSCs, and the biodistribution of BMMSCs will be demonstrated in subsequent studies. In summary, we employed three distinct imaging data processing methods to observe that the BMMSC transplantation enhances glucose metabolism in multiple functional brain regions, including hearing, movement, cognitive memory, vision, taste, and reproduction in aged macaques. This study reveals the application value of SPM8.0 in studying cerebral glucose metabolism in non-human primates, provides a reliable analytical tool for future research on healthy aging in humans and offers a theoretical basis for BMMSC-based therapies targeting specific brain disorders in the elderly. Conclusion Based on PET/CT imaging of the brain of macaques in different age and BMMSCs treatment groups, we observed the effect of BMMSCs in reversing brain aging in macaque using three different imaging data processing methods. Each method offers unique strengths: PET metabolic parameters provide a straightforward and efficient overview of global cerebral glucose metabolism trends, serving as an initial screening tool. Texture markers (SHAPE_Surface and GLZLM_LZLGE) enable granular classification of cortical states, capturing subtle structural patterns that complement metabolic data. SPM8.0 delivers high-precision localization of glucose metabolism differences across functional brain regions, though with greater computational complexity. While traditional PET parameters and texture analysis are rapid and practical for preliminary assessments, SPM8.0 adds spatially resolved quantitative rigor, making the combined approach indispensable for comprehensive evaluation. The integration of 18F-FDG PET/CT imaging, texture analysis, and SPM8.0 thus establishes a multimodal, non-invasive framework for validating BMMSCs efficacy, bridging preclinical findings to clinical translation. Future studies should leverage these complementary techniques to optimize stem cell therapy monitoring and standardization. We believe that our work offers a novel approach to evaluate stem cell therapy using non-invasive imaging and could serve as a basis for further translational research in both animal models and human studies. Limitations In the SPM8.0 analysis in this study, the PET images of the brains of 4 macaques were not well registered with the standard macaque brain template, resulting in the loss of 4 samples. If the sample size can be further expanded and juvenile macaques are included in the comparison, more precise differential brain regions will be obtained. A placebo-treated elderly control group would be valuable for future studies to further isolate BMMSC-specific effects. We did not have a sufficient sample size to include additional control groups, which constitutes a limitation of the current research. Only female macaques were included in this study for observation, and the same methods could be used for males to improve the study of differences between the sexes, which would be a more systematic reference for future studies of the human brain. The study protocol was not pre-registered in a public platform. However, the experimental design, imaging parameters, and statistical methods were finalized prior to data collection and are described in detail in the Methods section to ensure transparency and reproducibility. Future studies will be pre-registered in accordance with journal guidelines. Supplementary Material